Secretory immunity with special reference to the oral cavity

Per Brandtzaeg, Per Brandtzaeg

Abstract

The two principal antibody classes present in saliva are secretory IgA (SIgA) and IgG; the former is produced as dimeric IgA by local plasma cells (PCs) in the stroma of salivary glands and is transported through secretory epithelia by the polymeric Ig receptor (pIgR), also named membrane secretory component (SC). Most IgG in saliva is derived from the blood circulation by passive leakage mainly via gingival crevicular epithelium, although some may be locally produced in the gingiva or salivary glands. Gut-associated lymphoid tissue (GALT) and nasopharynx-associated lymphoid tissue (NALT) do not contribute equally to the pool of memory/effector B cells differentiating to mucosal PCs throughout the body. Thus, enteric immunostimulation may not be the best way to activate the production of salivary IgA antibodies although the level of specific SIgA in saliva may still reflect an intestinal immune response after enteric immunization. It remains unknown whether the IgA response in submandibular/sublingual glands is better related to B-cell induction in GALT than the parotid response. Such disparity is suggested by the levels of IgA in submandibular secretions of AIDS patients, paralleling their highly upregulated intestinal IgA system, while the parotid IgA level is decreased. Parotid SIgA could more consistently be linked to immune induction in palatine tonsils/adenoids (human NALT) and cervical lymph nodes, as supported by the homing molecule profile observed after immune induction at these sites. Several other variables influence the levels of antibodies in salivary secretions. These include difficulties with reproducibility and standardization of immunoassays, the impact of flow rate, acute or chronic stress, protein loss during sample handling, and uncontrolled admixture of serum-derived IgG and monomeric IgA. Despite these problems, saliva is an easily accessible biological fluid with interesting scientific and clinical potentials.

Keywords: IgA; IgG; crevicular fluid; gut-associated lymphoid tissue (GALT); mucosa-associated lymphoid tissue (MALT); mucosal vaccination; nasopharynx-associated lymphoid tissue (NALT); polymeric Ig receptor (pIgR); salivary glands; secretory component (SC).

Figures

Fig. 1
Fig. 1
Receptor-mediated epithelial export of polymeric Igs (pIgs). (A) Model for local generation of secretory IgA (SIgA) and secretory IgM (SIgM). J chain-containing dimeric IgA (IgA+J) and pentameric IgM (IgM+J) are produced by local plasma cells (left). Polymeric Ig receptor (pIgR), or membrane secretory component (SC), is synthesized by secretory epithelial cell in the rough endoplasmic reticulum and matures in the Golgi complex by terminal glycosylation (•-). In the trans-Golgi network (TGN), pIgR is sorted for delivery to the basolateral plasma membrane. The receptor becomes phosphorylated (-o) on a serine residue in its cytoplasmic tail. After endocytosis, ligand-complexed and unoccupied pIgR is delivered to basolateral endosomes and sorted for transcytosis to apical endosomes. Some recycling from basolateral endosomes to the basolateral surface may occur for unoccupied pIgR (not shown). Receptor recycling also takes place at the apical cell surface as indicated, although most pIgR is cleaved to allow extrusion of SIgA, SIgM and free SC to the lumen. During epithelial translocation, covalent stabilization of SIgA regularly occurs (disulfide bond between bound SC and one IgA subunit indicated), whereas free SC in secretions stabilizes the non-covalently bound SC in SIgM (dynamic equilibrium indicated). Modified from Brandtzaeg (17). (B) Paired immunofluorescence staining for pIgR/SC (red) and IgA (green) in normal parotid tissue. The specimen had been washed in phosphate-buffered saline to extract diffusible extracellular proteins before fixation in cold ethanol (16). IgA-producing plasma cells are scattered among acini but most of them occur adjacent to intercalated ducts. Note that there is variable uptake of IgA both in acini and ducts as evidenced by peripheral and some cytoplasmic staining of the epithelial cells (original magnification: ×250).
Fig. 2
Fig. 2
Elution patterns of Ig components in whole saliva after chromatography on Sephadex G-200 (column size, 2.5×37 cm; flow rate, 2.2 mL cm−2 h−1; fractions, 2.4 mL). Samples: 0.5 mL of 15 times concentrated unstimulated whole saliva from healthy individuals (left) or from patients with periodontitis (right). The distribution of Ig components was determined with specific antisera in single radial immunodiffusion (Mancini method) after three times concentration of the fractions. The squared diameters of the precipitin rings were used as concentration estimates. Modified from Brandtzaeg et al. (13).
Fig. 3
Fig. 3
Distribution of serum IgG in whole saliva and crevicular epithelium. (A) Regression line for the relationship between concentrations of IgG in whole saliva and the corresponding serum concentrations multiplied by the sum of the individual's periodontal index (PI) scores. Adapted from Brandtzaeg et al. (13). (B) Immunofluorescence demonstration of IgG (red) and IgA (green) in monkey gingiva that had been directly alcohol-fixed in situ before being removed from the tooth. Middle part of the crevicular epithelium is shown. IgG and IgA permeate the connective tissue and particularly IgG appears intercellularly in the epithelium (arrows) (original magnification: ×125). Unpublished experiments (Brandtzaeg P and Tolo K).
Fig. 4
Fig. 4
Secretion rates (µg/min/gland) of amylase, lactoferrin, free secretory component (SC), and secretory IgA (SIgA) in parotid fluid obtained before (unstimulated), during (stimulated), and after (rest) 80 min of acid gustatory stimulation of the secretion. Maximum average secretion rate in five subjects is for each component given as 100% on the vertical axis. Free SC and lactoferrin were undetectable in some stimulated samples, and data for these components are based on only four or three samples, respectively. Absolute figures (µg/min) and standard deviations (vertical lines) are therefore not indicated for the corresponding group maxima, while the average response for each component is indicated above the columns. Adapted from Brandtzaeg (39).
Fig. 5
Fig. 5
Merge of paired immunofluorescence staining for IgA (green) and IgM (red) in section of saline-extracted and ethanol-fixed specimen (16) of normal submandibular salivary gland. There is a dominance of IgA-producing plasma cells mainly adjacent to ducts. Note that there is a variable uptake mainly of IgA both in acini and ducts as evidenced by peripheral and some cytoplasmic staining of epithelial cells, but the luminal ring in striated duct at the middle top might represent adherent IgA from the secretion (original magnification: ×125).
Fig. 6
Fig. 6
Average tissue densities of plasmablasts and plasma cells producing different Ig classes at various normal secretory sites as indicated. Representative areas illustrating merge of immunofluorescence staining (see color key) are shown for submandibular gland and colonic lamina propria. Based on published data from the author's laboratory.
Fig. 7
Fig. 7
Merge of paired immunofluorescence staining for IgA (green) and IgG (red) in section of saline-extracted and ethanol-fixed specimen (16) of buccal minor salivary gland. Note that there is a relatively dense population of plasma cells compared with major salivary glands (cf. Fig. 5), and that IgG-producing cells are quite abundant at the periphery. Both ducts and serous parts of acini show faint selective staining for IgA, reflecting external transport (original magnification: ×80).
Fig. 8
Fig. 8
Relationship between local production of Ig isotypes by parotid plasma cells and Ig transfer by secretory epithelium. (A) Compared with the local production, export of IgA into stimulated parotid secretion is clearly favored over export of IgM (and IgG and IgD), whereas translocation of the two subclasses of IgA appears to be handled equally well by the glandular epithelium. (B) Comparison of epithelial translocation of dimeric IgA (pIgA) and pentameric IgM (pIgM) was performed in vitro with polarized MDCK cells transfected with the human polymeric Ig receptor. Cells were incubated with 125I-labelled pIgA or pIgM for 2 h at 4oC, washed for 10 min at 4oC, and chased at 37oC for different times as indicated. Translocation is expressed as the cumulative appearance of 125I-pIgA and 125I-pIgM in the apical medium. Each point represents mean result of three filters for pIgA and pIgM translocation at 50 nM ligand concentration. Adapted from Norderhaug et al. (29).
Fig. 9
Fig. 9
Generation of secretory IgA (SIgA) and free secretory component (SC). SIgA is formed as a hybrid antibody molecule stabilized by a disulfide bridge between the two cell products. The amount of dimeric IgA (pIgA) produced by a plasma cell depends on its level of J-chain expression, which generally is high in mucosal and glandular tissue. Inset (left) shows direct demonstration of abundant cytoplasmic expression of pIgA (p) in most parotid plasmablasts and plasma cells achieved by in vitro affinity test with free SC on tissue section as described (10), whereas a single cell producing only monomers (m) is seen in this field. On average, approximately 50% of SC occurring in various secretions is in a free form (unoccupied by ligand). The immunostained panel is from Brandtzaeg (43).
Fig. 10
Fig. 10
Relative production of Ig classes and IgA subclasses at human secretory effector sites. (A) Average percentage distribution of plasmablasts and plasma cells producing different Ig classes in various human secretory tissues from healthy controls and subjects with selective IgA deficiency. Based on published data of the author's laboratory. (B) Average percentage subclass distribution of IgA-producing plasmablasts and plasma cells in human lymphoid and normal secretory tissues. Based on published data from the author's laboratory except data for bronchial mucosa. Adapted from Brandtzaeg and Johansen (34).
Fig. 11
Fig. 11
Effect of tonsillar immunization with killed Streptococcus sobrinus on experimental bacterial tooth colonization and dental caries in a rabbit model. Comparison is made with results obtained in non-immunized (top) or non-inoculated (bottom) rabbits and after systemic or intragastric (enteric) immunization. Adapted from Fukuizumi et al. (94).
Fig. 12
Fig. 12
Homing properties of human mucosal memory/effector B cells. Putative scheme for compartmentalized migration of B cells from inductive (top) to effector (bottom) sites. Depicted are more or less preferred pathways (graded arrows) presumably followed by mucosal B cells activated in nasopharynx-associated lymphoid tissue (NALT) represented by palatine tonsils and adenoids, bronchus-associated lymphoid tissue (BALT), and gut-associated lymphoid tissue (GALT) represented by Peyer's patches, appendix, and colonic-rectal isolated lymphoid follicles. The principal homing receptor profiles of the respective B-cell populations, and adhesion/chemokine cues directing extravasation at different effector sites, are indicated (pink and blue panels) – those operating in lactating mammary glands apparently being shared for NALT- and GALT-derived cells. Homing molecules integrating airway immunity with systemic immunity are encircled in red. Adapted from Brandtzaeg (130).
Fig. 13
Fig. 13
Development of the secretory IgA (SIgA) system in parotid glands and saliva. (A) Ontogeny of Ig-producing cells and epithelial expression of the polymeric Ig receptor (pIgR/SC) in parotid glands. Based on data from Thrane et al. (46). (B) Ontogeny of SIgA as determined in unstimulated whole saliva. Based on data from Fitzsimmons et al. (114). Note that both the density of IgA+ plasmablasts and plasma cells as well as the SIgA level at about 6 months of age has to increase approximately 5 times to match the adult values.
Fig. 14
Fig. 14
Synopses of functional properties of salivary IgA with the structural basis for the excellent antimicrobial binding activity of secretory IgA (SIgA). (A) Direct immunofluorescence staining of salivary sediment to demonstrate IgA adsorbed onto oral bacteria in vivo. Epithelial cell is faintly visualized because of autofluorescence. Numerous cocci (mainly diplococci) – partly adhering to epithelial cell – are coated with IgA, which is also bound to the older cell-wall segments of streptococci forming long chains, whereas new crosswalls formed in vitro after sampling are negative as indicated. Adapted from Brandtzaeg et al. (66) (original magnification: ×2000). (B) Domain interactions in the formation of SIgA based on data reviewed in Norderhaug et al. (29). Non-covalent domain interactions are shown between the J chain (J) and the extracellular domain 1 (D1) of bound SC, and covalent disulfide bonding is indicated between cystein 467 or 502 in D5 of SC and cystein 311 in the Cα2 domain of one of the two IgA subunits. Some studies have indicated that there may be two J chains in dimeric IgA (30). Insert to the lower left is from modeling data for dimeric IgA1 based on X-ray and neutron scattering in solutions published in Bonner et al. (137). Note the T-shape of the Fab fragments, allowing for antibody binding to large particles like bacteria. V, variable region; C, constant region; L, light chain; H, heavy chain; Fab, fragment antigen binding; Fc, fragment crystallizable.

References

    1. Gordon BL. The romance of medicine. The story of the evolution of medicine from occult practices and primitive times. Philadelphia: Davis Co.; 1945.
    1. Besredka A. De la vaccination contre les états typhoides par la voie buccale. Ann Inst Pasteur. 1919;33:882–903.
    1. Davies A. An investigation into the serological properties of dysentery stools. Lancet. 1922;2:1009–12.
    1. Besredka A. Local immunization. Baltimore: Williams & Wilkins Company; 1927.
    1. Pierce AE. Specific antibodies at mucous surfaces. Vet Rev Annot. 1959;5:17–36.
    1. Ellison SA, Mashimo PA, Mandel ID. Immunochemical studies of human saliva. I. The demonstration of serum proteins in whole and parotid saliva. J Dent Res. 1960;39:892–8.
    1. Hanson LÅ, Brandtzaeg P. The discovery of secretory IgA and the mucosal immune system. Immunol Today. 1993;14:416–7.
    1. Tomasi TB, Tan EM, Solomon A, Prendergast RA. Characteristics of an immune system common to certain external secretions. J Exp Med. 1965;121:101–24.
    1. Crabbé PA, Carbonara AO, Heremans JF. The normal human intestinal mucosa as a major source of plasma cells containing γA-immunoglobulin. Lab Invest. 1965;14:235–48.
    1. Brandtzaeg P. Two types of IgA immunocytes in man. Nat New Biol. 1973;243:142–3.
    1. Brandtzaeg P. Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature. 1974;252:418–20.
    1. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Immunoglobulin M: local synthesis and selective secretion in patients with immunoglobulin A deficiency. Science. 1968;160:789–91.
    1. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol Suppl. 1970;12:1–83.
    1. Brandtzaeg P. Human secretory immunoglobulin M. An immunochemical and immunohistochemical study. Immunology. 1975;29:559–70.
    1. Nagura H, Brandtzaeg P, Nakane PK, Brown WR. Ultrastructural localization of J chain in human intestinal mucosa. J Immunol. 1979;123:1044–50.
    1. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology. 1974;26:1101–4.
    1. Brandtzaeg P. Mucosal and glandular distribution of immunoglobulin components. Differential localization of free and bound SC in secretory epithelial cells. J Immunol. 1974;112:1553–9.
    1. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature. 1984;311:71–3.
    1. Krajči P, Grzeschik KH, Geurts van Kessel AHM, Olaisen B, Brandtzaeg P. The human transmembrane secretory component (poly-Ig receptor): molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization. Hum Genet. 1991;87:642–8.
    1. Johansen F-E, Brandtzaeg P. Transcriptional regulation of the mucosal IgA system. Trends Immunol. 2004;25:150–7.
    1. Brandtzaeg P, Halstensen TS, Huitfeldt HS, Krajci K, Kvale D, Scott H, et al. Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract. Ann NY Acad Sci. 1992;664:157–79.
    1. Piskurich JF, Youngman KR, Phillips KM, Hempen PM, Blanchard MH, France JA, et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-γ. Molec Immunol. 1997;34:75–91.
    1. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol. 2012;189:4666–73.
    1. Brandtzaeg P. Gate-keeper function of the intestinal epithelium. Benef Microbes. 2013;4:67–82.
    1. Sletten K, Christensen TB, Brandtzaeg P. Human secretory component – III. Carbohydrates, amino acids and N-terminal sequence. Immunochemistry. 1975;12:783–5.
    1. Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol. 2010;5:817–29.
    1. Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol. 2008;1:31–7.
    1. Brandtzaeg P. Human secretory immunoglobulins. 4. Quantitation of free secretory piece. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79:189–203.
    1. Norderhaug IN, Johansen F-E, Schjerven H, Brandtzaeg P. Regulation of the formation and external transport of secretory immunoglobulins. Crit Rev Immunol. 1999;19:481–508.
    1. Brandtzaeg P. Human secretory component – VI. Immunoglobulin-binding properties. Immunochemistry. 1977;14:179–88.
    1. Vaerman J-P, Langendries AE, Giffroy DA, Kaetzel CS, Fiani CM, Moro I, et al. Antibody against the human J chain inhibits polymeric Ig receptor-mediated biliary and epithelial transport of human polymeric IgA. Eur J Immunol. 1998;28:171–82.
    1. Johansen F-E, Braathen R, Brandtzaeg P. The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA. J Immunol. 2001;167:5185–92.
    1. Braathen R, Hohman VS, Brandtzaeg P, Johansen FE. Secretory antibody formation: conserved binding interactions between J chain and polymeric Ig receptor from humans and amphibians. J Immunol. 2007;178:1589–97.
    1. Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32–63.
    1. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996;272:54–60.
    1. Johansen FE, Braathen R, Brandtzaeg P. Role of J chain in secretory immunoglobulin formation. Scand J Immunol. 2000;52:240–8.
    1. Mosmann TR, Gravel Y, Williamson AR, Baumal R. Modification and fate of J chain in myeloma cells in the presence and absence of polymeric immunoglobulin secretion. Eur J Immunol. 1978;8:94–101.
    1. Brandtzaeg P, Berdal P. J chain in malignant human IgG immunocytes. Scand J Immunol. 1975;4:403–7.
    1. Brandtzaeg P. Human secretory immunoglobulins. VII. Concentrations of parotid IgA and other secretory proteins in relation to the rate of flow and duration of secretory stimulus. Arch Oral Biol. 1971;16:1295–310.
    1. Brandtzaeg P. Salivary immunoglobulins. In: Tenovuo JO, editor. Human saliva: clinical chemistry and microbiology. vol. II. Boca Raton, FL: CRC Press; 1989. pp. 1–54.
    1. Natvig IB, Johansen FE, Nordeng TW, Haraldsen G, Brandtzaeg P. Mechanism for enhanced external transfer of dimeric IgA over pentameric IgM: studies of diffusion, binding to the human polymeric Ig receptor, and epithelial transcytosis. J Immunol. 1997;159:4330–40.
    1. Delacroix DL, Vaerman JP. Function of the human liver in IgA homeostasis in plasma. Ann NY Acad Sci. 1983;409:383–401.
    1. Brandtzaeg P. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells. Mol Immunol. 1983;20:941–66.
    1. Brandtzaeg P. Local formation and transport of immunoglobulins related to the oral cavity. In: MacPhee IT, editor. Host resistance to commensal bacteria. London: Churchill Livingstone; 1972. pp. 116–50.
    1. Booth CK, Dwyer DB, Pacque PF, Ball MJ. Measurement of immunoglobulin A in saliva by particle-enhanced nephelometric immunoassay: sample collection, limits of quantitation, precision, stability and reference range. Ann Clin Biochem. 2009;46:401–6.
    1. Thrane PS, Rognum TO, Brandtzaeg P. Ontogenesis of the secretory immune system and innate defence factors in human parotid glands. Clin Exp Immunol. 1991;86:342–8.
    1. Brandtzaeg P, Nilssen DE, Rognum TO, Thrane PS. Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am. 1991;20:397–439.
    1. Mellander L, Carlsson B, Jalil F, Soderstrom T, Hanson LA. Secretory IgA antibody response against Escherichia coli antigens in infants in relation to exposure. J Pediatr. 1985;107:430–3.
    1. Bosch JA. the Netherlands: Print partners Ipskamp B.V.; 2001. Stress and salivary defense systems. The effects of acute stressors on salivary composition and salivary function. Vrije University; p. 213. Research Thesis (Academisch Proefschrift), ISBN 90-9015363-2.
    1. Mandel ID, Khurana HS. The relation of human salivary γA globulin and albumin to flow rate. Arch Oral Biol. 1969;14:1433–5.
    1. Oon CH, Lee J. A controlled quantitative study of parotid salivary secretory IgA-globulin in normal adults. J Immunol Methods. 1972;2:45–8.
    1. Grönblad EA. Concentration of immunoglobulins in human whole saliva: effect of physiological stimulation. Acta Odontol Scand. 1982;40:87–95.
    1. Rudney JD, Smith QT. Relationships between levels of lysozyme, lactoferrin, salivary peroxidase, and secretory immunoglobulin A in stimulated parotid saliva. Infect Immun. 1985;49:469–75.
    1. Stuchell RN, Mandel ID. Studies of secretory IgA in caries-resistant and caries-susceptible adults. Adv Exp Med Biol. 1978;107:341–8.
    1. Gahnberg L, Krasse B. Salivary immunoglobulin A antibodies reacting with antigens from oral streptococci: longitudinal study in humans. Infect Immun. 1981;33:697–703.
    1. Rudney JD, Kajander KC, Smith QT. Correlations between human salivary levels of lysozyme, lactoferrin, salivary peroxidase and secretory immunoglobulin A with different stimulatory states and over time. Arch Oral Biol. 1985;30:765–71.
    1. Korsrud FR, Brandtzaeg P. Characterization of epithelial elements in human major salivary glands by functional markers: localization of amylase, lactoferrin, lysozyme, secretory component and secretory immunoglobulins by paired immunofluorescence staining. J Histochem Cytochem. 1982;20:657–66.
    1. Deslauriers N, Oudghiri M, Seguin J, Trudel L. The oral immune system: dynamics of salivary immunoglobulin production in the inbred mouse. Immunol Invest. 1986;15:339–49.
    1. Aase A, Sinnadurai K, Sack D, Fleckenstein JM, Sommerfelt H, Brandtzaeg P. The use of multiplex immunoassay and flow cytometry to measure salivary IgA against multiple enterotoxigenic Escherichia coli antigens. Abstract, 7th Conference on Global Health and Vaccination Research; 26–27 September; Trondheim. 2012.
    1. Widerström L, Bratthall D. Increased IgA levels in saliva during pregnancy. Scand J Dent Res. 1984;92:33–7.
    1. Kerr AC. The physiological regulation of salivary secretions in man. In: Greulich RC, MacDonald JB, Rushton MA, editors. International series of monographs on oral biology. Oxford: Pergamon Press; 1961.
    1. Tenovuo J, Lehtonen OP, Aaltonen AS, Vilja P, Tuohimaa P. Antimicrobial factors in whole saliva of human infants. Infect Immun. 1986;51:49–53.
    1. Crawford JM, Taubman MA, Smith DJ. Minor salivary glands as a major source of secretory immunoglobin A in the human oral cavity. Science. 1975;190:1206–9.
    1. Sonesson M, Hamberg K, Wallengren ML, Matsson L, Ericson D. Salivary IgA in minor-gland saliva of children, adolescents, and young adults. Eur J Oral Sci. 2011;119:15–20.
    1. Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol. 1991;83:203–9.
    1. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Adsorption of immunoglobulin A onto oral bacteria in vivo. J Bacteriol. 1968;96:242–9.
    1. Kristiansen BE. Collection of mucosal secretion by synthetic discs for quantitation of secretory IgA and bacteria. J Immunol Methods. 1984;73:251–7.
    1. Berg E, Tjell JC. Paraffin chewing as a saliva-stimulating agent. J Dent Res. 1969;48:325.
    1. Johansen FE, Pekna M, Norderhaug IN, Haneberg B, Hietala MA, Krajci P, et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med. 1999;190:915–22.
    1. Korsrud FR, Brandtzaeg P. Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands. Immunology. 1980;39:129–40.
    1. Brandtzaeg P. The secretory immune system of lactating human mammary glands compared with other exocrine organs. Ann NY Acad Sci. 1983;409:353–81.
    1. Brandtzaeg P. Immunohistochemical studies of various aspects of glandular immunoglobulin transport in man. Histochem J. 1977;9:553–72.
    1. Moro I, Umemura S, Cargo SS, Mestecky J. Immunohistochemical distribution of immmunoglobulins, lactoferrin, and lysozyme in human minor salivary glands. J Oral Pathol. 1984;13:97–104.
    1. Matthews JB, Potts AJC, Basu MK. Immunoglobulin-containing cells in normal human labial salivary glands. Int Arch Allergy Appl Immunol. 1985;77:374–6.
    1. Thrane PS, Sollid LM, Haanes HR, Brandtzaeg P. Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand J Immunol. 1992;35:43–51.
    1. Kilian M, Reinholdt J, Lomholt H, Poulsen K, Frandsen EV. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS. 1996;104:321–38.
    1. Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol. 1986;136:3631–5.
    1. Bonner A, Almogren A, Furtado PB, Kerr MA, Perkins SJ. Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity. Mucosal Immunol. 2009;2:74–84.
    1. Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest. 2010;39:303–55.
    1. Agnello D, Denimal D, Lavaux A, Blondeau-Germe L, Lu B, Gerard NP, et al. Intra-rectal immunization and IgA antibody-secreting cell homing to the small intestine. J Immunol In press
    1. Johansen F-E, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P. Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood. 2005;106:593–600.
    1. Mestecky J, McGhee JR, Arnold RR, Michalek SM, Prince SJ, Babb JL. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest. 1978;61:731–7.
    1. Weisz-Carrington P, Roux ME, McWilliams M, Phillips-Quagliata JM, Lamm ME. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J Immunol. 1979;123:1705–8.
    1. Jackson DE, Lally ET, Nakamura MC, Montgomery PC. Migration of IgA-bearing lymphocytes into salivary glands. Cell Immunol. 1981;63:203–9.
    1. Czerkinsky C, Svennerholm AM, Quiding M, Jonsson R, Holmgren J. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun. 1991;59:996–1001.
    1. al-Bayaty HF, Aldred MJ, Walker DM, Newcombe RG, Swift G, Smith PM, et al. Salivary and serum antibodies to gliadin in the diagnosis of celiac disease. J Oral Pathol Med. 1989;18:578–81.
    1. Hakeem V, Fifield R, al-Bayaty HF, Aldred MJ, Walker DM, Williams J, et al. Salivary IgA antigliadin antibody as a marker for coeliac disease. Arch Dis Child. 1992;67:724–7.
    1. Jertborn M, Svennerholm AM, Holmgren J. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol. 1986;24:203–9.
    1. Brandtzaeg P. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am J Respir Crit Care Med. 2011;183:1595–604.
    1. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol. 2003;67(Suppl. 1):S69–76.
    1. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol. 2004;4:699–710.
    1. Kuper CF, Koornstra PJ, Hameleers DM, Biewenga J, Spit BJ, Duijvestijn AM, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today. 1992;13:219–24.
    1. Nair PNR, Schroeder HE. Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. Immunology. 1986;57:171–80.
    1. Fukuizumi T, Inoue H, Tsujisawa T, Uchiyama C. Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits. Infect Immun. 1999;67:426–8.
    1. Sun Y, Shi W, Yang JY, Zhou DH, Chen YQ, Zhang Y, et al. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J Dent Res. 2012;91:941–7.
    1. Quiding-Järbrink M, Granström G, Nordström I, Holmgren J, Czerkinsky C. Induction of compartmentalized B-cell responses in human tonsils. Infect Immun. 1995;63:853–7.
    1. Stoltenberg L, Vege A, Saugstad OD, Rognum TO. Changes in the concentration and distribution of immunoglobulin-producing cells in SIDS palatine tonsils. Pediatr Allergy Immunol. 1995;6:48–55.
    1. Thrane P, Rognum TO, Brandtzaeg P. Increased immune response in upper respiratory and digestive tracts in SIDS. Lancet. 1990;335:229–30.
    1. Gleeson M, Clancy RL, Cripps AW. Mucosal immune response in a case of sudden infant death syndrome. Pediatr Res. 1993;33:554–6.
    1. Brandtzaeg P. Regionalized immune function of tonsils and adenoids. Immunol Today. 1999;20:383–4.
    1. Czerkinsky C, Cuburu N, Kweon MN, Anjuere F, Holmgren J. Sublingual vaccination. Hum Vaccin. 2011;7:110–4.
    1. Kulis M, Saba K, Kim EH, Bird JA, Kamilaris N, Vickery BP, et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol. 2012;129:1159–62.
    1. Ogra PL. Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. New Engl J Med. 1971;284:59–64.
    1. Jeschke R, Ströder J. Verlaufsbeobachtung klinischer und immunologischer Parameter, insbesondere des Speichel-IgA, bei tonsillektomierten. Kindern Klin Pädiat. 1980;192:51–60.
    1. D'Amelio R, Palmisano L, Le Moli S, Seminara R, Aiuti F. Serum and salivary IgA levels in normal subjects: comparison between tonsillectomized and non-tonsillectomized subjects. Int Archs Allergy Appl Immunol. 1982;68:256–9.
    1. Cantani A, Bellioni P, Salvinelli F, Businco L. Serum immunoglobulins and secretory IgA deficiency in tonsillectomized children. Ann Allergy. 1986;57:413–6.
    1. Lenander-Lumikari M, Tenovuo J, Puhakka HJ, Malvaranta T, Ruuskanen O, Meurman O, et al. Salivary antimicrobial proteins and mutans streptococci in tonsillectomized children. Pediatr Dent. 1992;14:86–91.
    1. Kirstila V, Tenovuo J, Ruuskanen O, Suonpaa J, Meurman O, Vilja P. Longitudinal analysis of human salivary immunoglobulins, non-immune antimicrobial agents, and microflora after tonsillectomy. Clin Immunol Immunopathol. 1996;80:110–5.
    1. Östergaard PA. IgA levels and carrier rate of pathogenic bacteria in 27 children previously tonsillectomized. Acta Path Microbiol Scand Sect C. 1977;85:178–86.
    1. Hess M, Kugler J, Haake D, Lamprecht J. Reduced concentration of secretory IgA indicates changes of local immunity in children with adenoid hyperplasia and secretory otitis media. ORL J Otorhinolaryngol Relat Spec. 1991;53:339–41.
    1. Gleeson M, Cripps AW, Clancy RL. Modifiers of the human mucosal immune system. Immunol Cell Biol. 1995;73:397–404.
    1. Mellander L, Carlsson B, Hanson LA. Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction? Clin Exp Immunol. 1986;63:555–61.
    1. Bjerke K, Brandtzaeg P. Terminally differentiated human intestinal B cells. IgA and IgG subclass-producing immunocytes in the distal ileum, including Peyer's patches, compared with lymph nodes and palatine tonsils. Scand J Immunol. 1990;32:61–7.
    1. Fitzsimmons SP, Evans MK, Pearce CL, Sheridan MJ, Wientzen R, Cole MF. Immunoglobulin A subclasses in infants’ saliva and in saliva and milk from their mothers. J Pediatr. 1994;124:566–73.
    1. Burgio GR, Lanzavecchia A, Plebani A, Jayakar S, Ugazio AG. Ontogeny of secretory immunity: levels of secretory IgA and natural antibodies in saliva. Pediatr Res. 1980;14:1111–4.
    1. Roberts SA, Wincup G, Harries DA. Mucosal receptor for IgA in the breast-fed neonate. Early Hum Dev. 1980;4:161–6.
    1. Cripps AW, Gleeson M, Clancy RL. Molecular characteristics of IgA in infant saliva. Scand J Immunol. 1989;29:317–24.
    1. Smith DJ, King WF, Taubman MA. Isotype, subclass and molecular size of immunoglobulins in salivas from young infants. Clin Exp Immunol. 1989;76:97–102.
    1. Fagerås M, Tomičić S, Voor T, Björkstén B, Jenmalm MC. Slow salivary secretory IgA maturation may relate to low microbial pressure and allergic symptoms in sensitized children. Pediatr Res. 2011;70:572–7.
    1. Carlsson B, Zaman S, Mellander L, Jalil F, Hanson LA. Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination. J Infect Dis. 1985;152:1238–44.
    1. Mellander L, Carlsson B, Hanson LA. Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. J Pediatr. 1984;104:564–8.
    1. Avanzini MA, Plebani A, Monafo V, Pasinetti G, Teani M, Colombo A, et al. A comparison of secretory antibodies in breast-fed and formula-fed infants over the first six months of life. Acta Paediatr. 1992;81:296–301.
    1. Stephensen CB, Moldoveanu Z, Gangopadhyay NN. Vitamin A deficiency diminishes the salivary immunoglobulin A response and enhances the serum immunoglobulin G response to influenza A virus infection in BALB/c mice. J Nutr. 1996;126:94–102.
    1. Glass RI, Svennerholm AM, Stoll BJ, Khan MR, Huda S, Huq MI, et al. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine. Pediatr Infect Dis J. 1989;8:105–9.
    1. Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med. 1998;4:601–6.
    1. Brown TA, Mestecky J. Immunoglobulin A sublass distribution of naturally occurring salivary antibodies to microbial antigens. Infect Immun. 1985;49:459–62.
    1. Mansa B, Kilian M. Retained antigen-binding activity of Fab fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease. Infect Immun. 1986;52:171–4.
    1. Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA. 2003;100:4215–20.
    1. Taylor HP, Dimmock NJ. Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG. J Exp Med. 1985;161:198–209.
    1. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol. 2009;70:505–15.
    1. Tsuruta T, Inoue R, Nojima I, Tsukahara T, Hara H, Yajima T. The amount of secreted IgA may not determine the secretory IgA coating ratio of gastrointestinal bacteria. FEMS Immunol Med Microbiol. 2009;56:185–9.
    1. Christensen P, Oxelius V-A. A reaction between some streptococci and IgA myeloma proteins. Acta Pathol Microbiol Scand C. 1975;83:184–8.
    1. Bollinger RR, Everett ML, Wahl SD, Lee YH, Orndorff PE, Parker W. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol. 2006;43:378–87.
    1. Murthy AK, Chaganty BK, Troutman T, Guentzel MN, Yu JJ, Ali SK, et al. Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation. PLoS One. 2011;6:e16847.
    1. Renegar KB, Jackson GD, Mestecky J. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol. 1998;160:1219–23.
    1. Biesbrock AR, Reddy MS, Levine MJ. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun. 1991;59:3492–7.
    1. Bonner A, Furtado PB, Almogren A, Kerr MA, Perkins SJ. Implications of the near-planar solution structure of human myeloma dimeric IgA1 for mucosal immunity and IgA nephropathy. J Immunol. 2008;180:1008–18.
    1. Quan C, Berneman A, Pires R, Avrameas S, Bouvet JP. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible immune barrier in humans. Infect Immun. 1997;65:3997–4004.
    1. Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, et al. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest. 2011;121:1946–55.
    1. Di Niro R, Mesin L, Zheng NY, Stamnaes J, Morrissey M, Lee JH, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med. 2012;18:441–5.
    1. Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M, et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J Exp Med. 2012;209:2079–97.
    1. Rogosch T, Kerzel S, Hoß K, Hoersch G, Zemlin C, Heckmann M, et al. IgA response in preterm neonates shows little evidence of antigen-driven selection. J Immunol. 2012;189:5449–56.
    1. Nogueira RD, Sesso ML, Borges MC, Mattos-Graner RO, Smith DJ, Ferriani VP. Salivary IgA antibody responses to Streptococcus mitis and Streptococcus mutans in preterm and fullterm newborn children. Arch Oral Biol. 2012;57:647–53.
    1. Dunn-Walters DK, Hackett M, Boursier L, Ciclitira PJ, Morgan P, Challacombe SJ, et al. Characteristics of human IgA and IgM genes used by plasma cells in the salivary gland resemble those used in duodenum but not those used in the spleen. J Immunol. 2000;164:1595–601.
    1. Stoel M, Evenhuis WN, Kroese FG, Bos NA. Rat salivary gland reveals a more restricted IgA repertoire than ileum. Mol Immunol. 2008;45:719–27.
    1. Kawamoto S, Tran TH, Maruya M, Suzuki K, Doi Y, Tsutsui Y, et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science. 2012;336:485–9.
    1. van der Waaij LA, Limburg PC, Mesander G, van der Waaij D. In vivo IgA coating of anaerobic bacteria in human faeces. Gut. 1996;38:348–54.
    1. De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, Calabuig M, et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 2010;10:63.
    1. Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;2:328–39.
    1. Spencer J, Klavinskis LS, Fraser LD. The human intestinal IgA response; burning questions. Front Immunol. 2012;3:108.
    1. Brandtzaeg P. The oral secretory immune system with special emphasis on its relation to dental caries. Proc Finn Dent Soc. 1983;79:71–84.
    1. Russell MW, Mestecky J. Potential for immunological intervention against dental caries. J Biol Buccale. 1986;14:159–75.
    1. Brandtzaeg P. Immunology of inflammatory periodontal lesions. Int Dent J. 1973;23:438–54.
    1. Nikfarjam J, Pourpak Z, Shahrabi M, Nikfarjam L, Kouhkan A, Moazeni M, et al. Oral manifestations in selective IgA deficiency. Int J Dent Hyg. 2004;2:19–25.
    1. Fernandes FR, Nagao AT, Mayer MP, Zelante F, Carneiro-Sampaio MM. Compensatory levels of salivary IgM anti-Streptococcus mutans antibodies in IgA-deficient patients. J Investig Allergol Clin Immunol. 1995;5:151–5.
    1. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science. 2009;325:617–20.
    1. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–5.
    1. Ørstavik D, Brandtzaeg P. Secretion of parotid IgA in relation to gingival inflammation and dental caries experience in man. Arch Oral Biol. 1975;20:701–4.
    1. Taubman MA, Smith DJ. Significance of salivary antibody in dental disease. Ann NY Acad Sci. 1993;694:202–15.
    1. Nogueira RD, Alves AC, Napimoga MH, Smith DJ, Mattos-Graner RO. Characterization of salivary immunoglobulin A responses in children heavily exposed to the oral bacterium Streptococcus mutans: influence of specific antigen recognition in infection. Infect Immun. 2005;73:5675–84.
    1. Gregory RL, Filler SJ. Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans . Infect Immun. 1987;55:2409–15.
    1. Gregory RL, Michalek SM, Filler SJ, Mestecky J, McGhee JR. Prevention of Streptococcus mutans colonization by salivary IgA antibodies. J Clin Immunol. 1985;5:55–62.
    1. Russell MW, Childers NK, Michalek SM, Smith DJ, Taubman MA. A caries vaccine? The state of the science of immunization against dental caries. Caries Res. 2004;38:230–5.
    1. Parisotto TM, King WF, Duque C, Mattos-Graner RO, Steiner-Oliveira C, Nobre-Dos-Santos M, et al. Immunological and microbiologic changes during caries development in young children. Caries Res. 2011;45:377–85.
    1. Ranadheer E, Nayak UA, Reddy NV, Rao VA. The relationship between salivary IgA levels and dental caries in children. J Indian Soc Pedod Prev Dent. 2011;29:106–12.
    1. Smith DJ, Ebersole JL, Taubman MA, Gadalla L. Salivary IgA antibody to Actinobacillus actinomyetemcomitans in young adult population. J Periodontal Res. 1985;20:8–11.
    1. Sato M, Nagata A, Maehara R, Endo J, Hinode D, Nakamura R. Salivary IgA antibody to Bacteroides gingivalis and Actinobacillus actinomycetemcomitans in patients with adult marginal periodontitis. J Dent Health. 1987;37:244–9. (in Japanese)
    1. Napimoga MH, Nunes LH, Maciel AA, Demasi AP, Benatti BB, Santos VR, et al. Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. Scand J Immunol. 2011;74:596–602.
    1. Lie MA, Myint MM, Schenck K, Timmerman MF, van der Velden U, van der Weijden GA, et al. Parotid salivary S-IgA antibodies during experimental gingivitis in smokers and non-smokers. J Periodontal Res. 2002;37:86–92.
    1. Olayanju OA, Rahamon SK, Joseph IO, Arinola OG. Salivary immunoglobulin classes in Nigerian smokers with periodontitis. World J Biol Chem. 2012;3:180–3.
    1. Brandtzaeg P, Nilssen DE. Mucosal aspects of primary B-cell deficiency and gastrointestinal infections. Curr Opin Gastroenterol. 1995;11:532–40.
    1. Östergaard PA. Predictable clinical disorders related to serum and saliva Ig-levels and the number of circulating T cells in asthmatic children. Clin Allergy. 1980;10:277–84.
    1. Mellander L, Björkander J, Carlsson B, Hanson LA. Secretory antibodies in IgA-deficient and immunosuppressed individuals. J Clin Immunol. 1986;6:284–91.
    1. Brandtzaeg P, Karlsson G, Hansson G, Petruson B, Björkander J, Hanson LA. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa. Clin Exp Immunol. 1987;67:626–36.
    1. Nakamura C, Akimoto T, Suzuki S, Kono I. Daily changes of salivary secretory immunoglobulin A and appearance of upper respiratory symptoms during physical training. J Sports Med Phys Fitness. 2006;46:152–7.
    1. van Asperen PP, Gleeson M, Kemp AS, Cripps AW, Geraghty SB, Mellis CM, et al. The relationship between atopy and salivary IgA deficiency in infancy. Clin Exp Immunol. 1985;62:753–7.
    1. Gleeson M, Clancy RL, Hensley MJ, Cripps AW, Henry RL, Wlodarczyk JH, et al. Development of bronchial hyperreactivity following transient absence of salivary IgA. Am J Respir Crit Care Med. 1996;153:1785–9.
    1. Lehtonen O-P J, Tenovuo J, Aaltonen AS, Vilja P. Immunoglobulins and innate factors of immunity in saliva of children prone to respiratory infections. Acta Pathol Microbiol Scand C. 1987;95:35–40.
    1. Östergaard PA. Oral bacterial flora and secretory IgA in small children after repeated courses of antibiotics. Scand J Infect Dis. 1983;15:115–8.
    1. Groopman JE, Salahuddin SZ, Sarngadharan MG, Markham PD, Gonda M, Sliski A, et al. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science. 1984;226:447–9.
    1. Pekovic D, Ajdukovic D, Tsoukas C, Lapointe N, Michaud J, Gilmore N, et al. Detection of human immunosuppressive virus in salivary lymphocytes from dental patients with AIDS. Am J Med. 1987;52:188–9.
    1. Challacombe SJ, Naglik JR. The effects of HIV infection on oral mucosal immunity. Adv Dent Res. 2006;19:29–35.
    1. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins following HIV-1 infection. J Acquir Immune Defic Syndr. 1990;3:41–8.
    1. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med. 1992;21:209–13.
    1. Nilssen DE, Øktedalen O, Brandtzaeg P. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut. 2004;53:487–93.
    1. Sweet SP, Rahman D, Challacombe SJ. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology. 1995;86:556–9.
    1. Matsuda S, Oka S, Honda M, Takebe Y, Takemori T. Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand J Immunol. 1993;38:428–34.
    1. Myint MM, Steinsvoll S, Odden K, Dobloug J, Schenck K. Salivary IgA responses to bacteria in dental plaque as related to periodontal and HIV infection status. Eur J Oral Sci Dec. 1997;105:562–70.
    1. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2:416–22.
    1. Brandtzaeg P, Tolo K. Mucosal penetrability enhanced by serum-derived antibodies. Nature. 1977;266:262–3.
    1. Persson CG, Erjefalt JS, Greiff L, Erjefält I, Korsgren M, Linden M, et al. Contribution of plasma-derived molecules to mucosal immune defence, disease and repair in the airways. Scand J Immunol. 1998;47:302–13.
    1. Lu XS, Delfraissy JF, Grangeot-Keros L, Rannou MT, Pillot J. Rapid and constant detection of HIV antibody response in saliva of HIV-infected patients; selective distribution of anti-HIV activity in the IgG isotype. Res Virol. 1994;145:369–77.
    1. Hunt AJ, Connell J, Christofinis G, Parry JV, Weatherburn P, Hickson FC, et al. The testing of saliva samples for HIV-1 antibodies: reliability in a non-clinic setting. Genitourin Med. 1993;69:29–30.
    1. Wright AA, Katz IT. Home testing for HIV. N Engl J Med. 2006;354:437–40.
    1. Nielsen AA, Nielsen JN, Schmedes A, Brandslund I, Hey H. Saliva interleukin-6 in patients with inflammatory bowel disease. Scand J Gastroenterol. 2005;40:1444–8.

Source: PubMed

3
Subscribe